Sunshine Biopharma (SBFM) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Sunshine Biopharma (SBFM) over the last 6 years, with Q3 2025 value amounting to $240067.0.
- Sunshine Biopharma's Other Gross PP&E Adjustments rose 14433.63% to $240067.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $240067.0, marking a year-over-year increase of 14433.63%. This contributed to the annual value of -$53449.0 for FY2024, which is 4120.99% up from last year.
- Sunshine Biopharma's Other Gross PP&E Adjustments amounted to $240067.0 in Q3 2025, which was up 14433.63% from $158163.0 recorded in Q2 2025.
- Sunshine Biopharma's Other Gross PP&E Adjustments' 5-year high stood at $240067.0 during Q3 2025, with a 5-year trough of -$728129.0 in Q1 2023.
- Moreover, its 4-year median value for Other Gross PP&E Adjustments was -$411911.0 (2022), whereas its average is -$320794.2.
- As far as peak fluctuations go, Sunshine Biopharma's Other Gross PP&E Adjustments skyrocketed by 1756.3% in 2024, and later surged by 14433.63% in 2025.
- Over the past 4 years, Sunshine Biopharma's Other Gross PP&E Adjustments (Quarter) stood at -$282354.0 in 2022, then skyrocketed by 67.8% to -$90915.0 in 2023, then soared by 41.21% to -$53449.0 in 2024, then surged by 549.15% to $240067.0 in 2025.
- Its last three reported values are $240067.0 in Q3 2025, $158163.0 for Q2 2025, and -$11923.0 during Q1 2025.